Story · Medicine & Biotech

AMP 2026: 700,000 Whole Tumor Transcriptomes Reveal Gene Fusion Targets

1 outlet · first reported by Inside Precision Medicine on

SEATTLE —In April, Mayo Clinic Laboratories introduced a whole-transcriptome sequencing (WTS) assay that interrogates approximately 20,000 genes, with clinical reporting focused on 1,445—a substantial expansion from its previous 138-gene sarcoma panel. The motivation was straightforward: cancer… (Inside Precision Medicine)

Coverage, in order

  1. AMP 2026: 700,000 Whole Tumor Transcriptomes Reveal Gene Fusion Targets

    SEATTLE —In April, Mayo Clinic Laboratories introduced a whole-transcriptome sequencing (WTS) assay that interrogates approximately 20,000 genes, with clinical reporting focused on 1,445—a substantial expansion from its previous 138-gene sarcoma panel. The motivation was straightforward: cancer…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.